Kim et al. (25) reported that a positive difference between cystatin C- and creatinine-eGFR in the KNOW-CKD cohort was associated with a higher risk of CVEs and accelerated coronary artery calcification. This evidence concerns the gene CST3 and coronary artery calcification.